The treatment landscape of generalised myasthenia gravis, a prototypic antibody-mediated disorder of the neuromuscular junction, has considerably evolved in the past 8 years.1 The approval of targeted ...
“We are restoring an icon and creating a new destination - something Preston can be proud of.” The long-awaited restoration of a Preston landmark has been given the green light after developers ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results